Manoussos Perros

Insider Reports History

Entity
Individual
Location
C/O Entasis Therapeutics Holdings Inc., 35 Gatehouse Drive, Waltham, MA
Signature
Elizabeth M. Keiley as Attorney-in-Fact for Manoussos Perros
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Manoussos Perros:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entasis Therapeutics Holdings Inc. President and CEO, Director Common Stock 0 $2.20 Jul 11, 2022 Direct
Entasis Therapeutics Holdings Inc. President and CEO, Director Stock Option (right to buy) 0 Jul 11, 2022 Direct

Insider Reports Filed by Manoussos Perros

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ETTX Entasis Therapeutics Holdings Inc. Jul 7, 2022 6 -$123K 4 Jul 11, 2022 President and CEO, Director
ETTX Entasis Therapeutics Holdings Inc. Jan 18, 2022 1 $0 4 Jan 19, 2022 President and Chief Executive Officer
ETTX Entasis Therapeutics Holdings Inc. Nov 2, 2021 1 -$34.4K 4 Nov 3, 2021 President and CEO, Director
ETTX Entasis Therapeutics Holdings Inc. Oct 19, 2021 2 -$38.2K 4 Oct 20, 2021 President and Chief Executive Officer, Director
ETTX Entasis Therapeutics Holdings Inc. Jul 16, 2021 8 $0 4 Feb 15, 2022 President and CEO